Contact

Midland Health Planning & Marketing 
(432) 221-1185

Email

Midland Health Introduces Aquablation Therapy for Treatment of Benign Prostatic Hyperplasia, a Condition that Impacts Millions of Men

Posted On: 11/2/2026

For Immediate Release

November 2, 2026

Midland Health Introduces Aquablation Therapy for Treatment of Benign Prostatic Hyperplasia, a Condition that Impacts Millions of Men


Midland Health and West Texas Urology announced that it is the only healthcare facility in the Midland/Odessa area to offer Aquablation® therapy for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). Midland Health is shining the spotlight on this advanced, minimally invasive robotic-assisted procedure that uses the power of water to remove obstructive prostate tissue and provide clinically proven, long-lasting BPH symptom relief while preserving sexual function and continence across all shapes and sizes.

BPH is a condition in which the prostate gland enlarges, leading to various urinary symptoms. Without timely treatment, BPH can lead to severe health issues such as permanent bladder or kidney damage, bladder stones and incontinence. Common symptoms of BPH include frequent need to urinate, especially at night, difficulty starting urination, a weak or interrupted urine stream, the inability to completely empty the bladder and dribbling at the end of urination. BPH is a highly prevalent condition, particularly affecting older men. BPH affects one out of every two males between the ages of 51 and 60, and an overwhelming 99% of men with BPH report that the condition negatively impacts their overall quality of life.

Aquablation therapy is the first and only ultrasound-guided, robotic-assisted, heat-free waterjet for the treatment of BPH. The system’s real-time ultrasound imaging provides the surgeon with a multi-dimensional view of the prostate, enabling personalized treatment planning tailored to each patient’s unique anatomy. The surgeon can specify which areas of the prostate to remove while preserving the anatomy that controls erectile function, ejaculatory function and continence. Once the treatment plan is mapped by the surgeon, the predictable robotic-assisted execution enables prostate tissue to be removed in a precise, targeted and controlled fashion.

“We are proud to be among the first in the Permian Basin to offer a solution for men with BPH that provides significant, long-lasting symptom relief with lower risk to their sexual function or continence compared to other treatment options. We are shining the spotlight on men’s health and Aquablation therapy, addressing the need to deliver durable outcomes that are safe, effective and consistent across all prostate sizes and shapes.” Tim Simecek, Director of Perioperative Services

Aquablation therapy is the next step in furthering Midland Health’s commitment to robotic surgery and men’s health.

For more information on Aquablation therapy, visit aquablation.com.

Media Contact:
Tasa Richardson, Director of Planning, Marketing and Communications
tasa.richardson@midlandhealth.org

back to top